Fluidigm Debt to Equity Ratio 2008-2019 | FLDM
Fluidigm Debt/Equity Ratio Historical Data | |||
---|---|---|---|
Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
2019-09-30 | $0.05B | $0.16B | 0.33 |
2019-06-30 | $0.06B | $0.17B | 0.32 |
2019-03-31 | $0.06B | $0.18B | 0.30 |
2018-12-31 | $0.17B | $0.07B | 2.39 |
2018-09-30 | $0.17B | $0.02B | 7.56 |
2018-06-30 | $0.17B | $0.04B | 4.79 |
2018-03-31 | $0.16B | $0.05B | 3.38 |
2017-12-31 | $0.20B | $0.03B | 6.31 |
2017-09-30 | $0.20B | $0.04B | 5.00 |
2017-06-30 | $0.20B | $0.02B | 8.15 |
2017-03-31 | $0.20B | $0.04B | 5.07 |
2016-12-31 | $0.20B | $0.05B | 3.66 |
2016-09-30 | $0.20B | $0.07B | 2.87 |
2016-06-30 | $0.20B | $0.08B | 2.31 |
2016-03-31 | $0.20B | $0.10B | 1.97 |
2015-12-31 | $0.20B | $0.12B | 1.69 |
2015-09-30 | $0.20B | $0.12B | 1.58 |
2015-06-30 | $0.20B | $0.13B | 1.47 |
2015-03-31 | $0.20B | $0.14B | 1.37 |
2014-12-31 | $0.20B | $0.15B | 1.30 |
2014-09-30 | $0.20B | $0.16B | 1.26 |
2014-06-30 | $0.20B | $0.16B | 1.21 |
2014-03-31 | $0.20B | $0.17B | 1.17 |
2013-12-31 | $0.00B | $0.10B | 0.00 |
2013-09-30 | $0.00B | $0.10B | 0.00 |
2013-06-30 | $0.00B | $0.10B | 0.00 |
2013-03-31 | $0.00B | $0.10B | 0.00 |
2012-12-31 | $0.00B | $0.10B | 0.00 |
2012-09-30 | $0.00B | $0.10B | 0.00 |
2012-06-30 | $0.00B | $0.05B | 0.00 |
2012-03-31 | $0.00B | $0.05B | 0.00 |
2011-12-31 | $0.00B | $0.06B | 0.02 |
2011-09-30 | $0.00B | $0.06B | 0.05 |
2011-06-30 | $0.01B | $0.06B | 0.08 |
2011-03-31 | $0.01B | $0.07B | 0.09 |
2010-12-31 | $0.01B | $-0.19B | -0.05 |
2010-09-30 | $0.01B | $-0.19B | -0.06 |
2010-06-30 | $0.00B | 0.00 | |
2010-03-31 | $0.00B | 0.00 | |
2009-09-30 | $0.00B | 0.00 | |
2008-03-31 | $0.01B | $-0.14B | -0.06 |
2007-12-31 | $0.01B | $-0.13B | -0.08 |
2007-03-31 | $0.00B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.166B | $0.113B |
Fluidigm Corporation operates as a biotech tools company that creates microfluidic-based chips and instrumentation for biological research. Products offered by the Company include BioMark HD System- a real time PCR; EP1 system for SNP genotyping; Access Array System-an Integrated Fluidic Circuit (IFC); TOPAZ system for protein crystallography; Dynamic Array integrated fluidic circuits (IFCs); and Access Array Assay Design Services. The Company's products find its application in Gene Expression, Single-Cell Gene Expression, SNP Genotyping, Targeted Resequencing, Sample Quantitation, Copy Number Variation and Protein Crystallization. Fluidigm Corporation is based in San Francisco, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $125.466B | 25.99 |
Intuitive Surgical (ISRG) | United States | $66.944B | 52.61 |
Edwards Lifesciences (EW) | United States | $51.008B | 46.32 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $21.998B | 14.89 |
IDEXX Laboratories (IDXX) | United States | $21.331B | 51.59 |
DexCom (DXCM) | United States | $20.929B | 187.43 |
Olympus (OCPNY) | Japan | $20.322B | 152.62 |
Teleflex (TFX) | United States | $16.317B | 33.13 |
Sysmex ADR (SSMXY) | Japan | $14.806B | 39.85 |
SONOVA HOLDING (SONVY) | Switzerland | $14.376B | 0.00 |
Hologic (HOLX) | United States | $13.860B | 21.18 |
STERIS (STE) | Ireland | $12.894B | 28.48 |
Varian Medical Systems (VAR) | United States | $12.305B | 29.17 |
ABIOMED (ABMD) | United States | $8.631B | 46.97 |
Masimo (MASI) | United States | $8.300B | 49.56 |
Penumbra (PEN) | United States | $5.971B | 194.35 |
SARTORIUS AG (SARTF) | Germany | $5.614B | 49.28 |
Globus Medical (GMED) | United States | $5.562B | 34.33 |
Integra LifeSciences Holdings (IART) | United States | $5.194B | 22.32 |
Elekta AB (EKTAY) | Sweden | $4.693B | 36.13 |
Tandem Diabetes Care (TNDM) | United States | $4.041B | 0.00 |
LivaNova (LIVN) | United Kingdom | $3.967B | 28.56 |
Wright Medical Group (WMGI) | Netherlands | $3.760B | 227.92 |
Nevro (NVRO) | United States | $3.491B | 0.00 |
Cantel Medical (CMD) | United States | $3.304B | 32.75 |
Integer Holdings (ITGR) | United States | $2.492B | 17.06 |
Nihon Kohden (NHNKY) | Japan | $2.389B | 24.04 |
Glaukos (GKOS) | United States | $2.224B | 0.00 |
Inogen (INGN) | United States | $1.615B | 50.99 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.592B | 31.34 |
Veracyte (VCYT) | United States | $1.283B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $1.166B | 133.26 |
Silk Road Medical (SILK) | United States | $1.074B | 0.00 |
Natus Medical (NTUS) | United States | $1.072B | 25.79 |
OPKO Health (OPK) | United States | $1.065B | 0.00 |
Mesa Laboratories (MLAB) | United States | $1.015B | 37.62 |
CryoLife (CRY) | United States | $0.926B | 94.92 |
Luminex (LMNX) | United States | $0.925B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.852B | 28.29 |
Accelerate Diagnostics (AXDX) | United States | $0.799B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.783B | 0.00 |
AxoGen (AXGN) | United States | $0.673B | 0.00 |
Intersect ENT (XENT) | United States | $0.665B | 0.00 |
Quotient (QTNT) | Switzerland | $0.579B | 0.00 |
AngioDynamics (ANGO) | United States | $0.573B | 20.59 |
OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
ViewRay (VRAY) | United States | $0.441B | 0.00 |
Oxford Immunotec Global (OXFD) | United Kingdom | $0.433B | 13.10 |
Si-Bone (SIBN) | United States | $0.433B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.422B | 0.00 |
Sientra (SIEN) | United States | $0.406B | 0.00 |
GenMark Diagnostics (GNMK) | United States | $0.317B | 0.00 |
Semler Scientific (SMLR) | United States | $0.291B | 39.27 |
Stereotaxis (STXS) | United States | $0.291B | 0.00 |
IRadimed (IRMD) | United States | $0.258B | 36.27 |
SeaSpine Holdings (SPNE) | United States | $0.250B | 0.00 |
Accuray (ARAY) | United States | $0.249B | 0.00 |
CRH Medical (CRHM) | Canada | $0.228B | 63.60 |
EDAP TMS S.A (EDAP) | France | $0.156B | 41.38 |
RTI Surgical (RTIX) | United States | $0.133B | 36.00 |
ConforMIS (CFMS) | United States | $0.124B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.109B | 0.00 |
Second Sight Medical Products (EYES) | United States | $0.107B | 0.00 |
Restoration Robotics (VERO) | Canada | $0.096B | 0.00 |
Neuronetics (STIM) | United States | $0.085B | 0.00 |
Electromed (ELMD) | United States | $0.084B | 30.00 |
Vermillion (VRML) | United States | $0.074B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.060B | 0.00 |
Apollo Endosurgery (APEN) | United States | $0.058B | 0.00 |
TransEnterix (TRXC) | United States | $0.048B | 0.00 |
Bioanalytical Systems (BASI) | United States | $0.047B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.042B | 0.00 |
HTG Molecular Diagnostics (HTGM) | United States | $0.038B | 0.00 |
Xtant Medical Holdings (XTNT) | United States | $0.023B | 0.00 |
Neovasc (NVCN) | Canada | $0.022B | 0.00 |
ReWalk Robotics (RWLK) | Israel | $0.021B | 0.00 |
Ra Medical Systems (RMED) | United States | $0.016B | 0.00 |
DarioHealth (DRIO) | Israel | $0.016B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.016B | 0.00 |
Navidea Biopharmaceuticals (NAVB) | United States | $0.016B | 0.00 |
American Shared Hospital Services (AMS) | United States | $0.015B | 21.07 |
OBALON THERPTCS (OBLN) | United States | $0.014B | 0.00 |
Avinger (AVGR) | United States | $0.014B | 0.00 |
Nanovibronix (NAOV) | United States | $0.013B | 0.00 |
Lianluo Smart (LLIT) | China | $0.011B | 0.00 |
Micron Solutions (MICR) | United States | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.007B | 0.00 |
Dynatronics (DYNT) | United States | $0.006B | 0.00 |
Allied Healthcare Products (AHPI) | United States | $0.004B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
InspireMD (NSPR) | Israel | $0.003B | 0.00 |
Sunshine Heart Inc (CHFS) | United States | $0.003B | 0.00 |
Viveve Medical (VIVE) | United States | $0.001B | 0.00 |